Showing results (21-30 of 102) with videos related to
Sort By:
Pageof 11
The Journal of Urology|August 23, 2000
CNS induced neurogenic cystitis is associated with bladder mast cell degranulation in the ratL Jasmin, G Janni, P T Ohara, et al.Human Gene Therapy|December 10, 1999
Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapyT Todo, S D Rabkin, A Chahlavi, et al.Human Gene Therapy|February 27, 1999
Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunityM Toda, S D Rabkin, H Kojima, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activityM Toda, R L Martuza, H Kojima, et al.Neoplasia (New York, N.Y.)|August 10, 2000
Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinomaA Chahlavi, T Todo, R L Martuza, et al.Journal of Virology|July 1, 1997
Transcriptional targeting of herpes simplex virus for cell-specific replicationS Miyatake, A Iyer, R L Martuza, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 21, 1998
Activation of CNS circuits producing a neurogenic cystitis: evidence for centrally induced peripheral inflammationL Jasmin, G Janni, H J Manz, et al.Journal of Virology|March 23, 2000
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation in miceP Sundaresan, W D Hunter, R L Martuza, et al.Cancer Research|February 24, 2001
In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunityT Todo, R L Martuza, M J Dallman, et al.Proceedings of the National Academy of Sciences of the United States of America|May 17, 2001
Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killingT Todo, R L Martuza, S D Rabkin, et al.Pageof 11